Featured Articles

Post-Inflammatory Hyperpigmentation: A Review of Treatment Strategies

By August 17, 2020August 19th, 2024No Comments

Featured Article

Featured Article

Post-inflammatory hyperpigmentation (PIH) is a reactive process resulting from increased melanin or abnormal distribution of melanin secondary to inflammatory skin conditions, dermatologic therapies, and external stimuli. Because PIH is a common condition that has a substantial effect on the quality of life, an understanding of its treatment modalities is essential. Though there are many therapeutic strategies for hyperpigmentary conditions such as melasma that are described in the literature, fewer studies focus on PIH. This article aims to provide a comprehensive literature review of therapies specifically used to treat PIH, such as topical combinations, chemical peels, and lasers.

Read more

This article aims to provide a comprehensive literature review of therapies specifically used to treat PIH, such as topical combinations, chemical peels, and lasers.

Adele Shenoy BA, Raman Madan MD

Post-inflammatory hyperpigmentation (PIH) is a reactive process resulting from increased melanin or abnormal distribution of melanin, secondary to inflammatory skin conditions such as acne, atopic dermatitis, contact dermatitis, and psoriasis, as well as external factors such as burns and radiation therapy. An understanding of treatment strategies for PIH is essential, as it has a large impact on the quality of life.

Though there are many therapeutic strategies for hyperpigmentary conditions such as melasma that are described in the literature, fewer studies specifically address PIH. Thus, we conducted a literature review on PubMed using key words “post-inflammatory hyperpigmentation” OR “postinflammatory hyperpigmentation.”

Studies that did not specifically address PIH and articles that were not published in English were excluded. Additional studies were obtained by scanning references. This review adds to the current literature by discussing the evidence for topical therapies, chemical peels, and laser therapy used specifically for hyperpigmentation from PIH.

Read Full Article Now
Article Cited in this Post

Inclusive Derm Atlas PIH Images

You May Also Like

Journal of Drugs in Dermatology JDD featuring GLP-1 Receptor Agonist Use for Diabetes Mellitus is Associated With Reduced Psoriasis Disease Severity

Hair Loss Awareness Month

| Featured Articles, Hair, Latest News | No Comments
Advancing Hair Loss Solutions As August marks Hair Loss Awareness Month, the Journal of Drugs in Dermatology (JDD) continues to champion evidence-based approaches for practicing dermatologists navigating this challenging field.…

“Please sir, I want some more:” When Rescue Becomes Routine With Prednisone in IBD Care

| Featured Articles, Latest News, Podcast, Podcast Highlights, The JDD Steroid Stewardship Podcast | No Comments
Guest: Dr. Adelina Hung For decades, corticosteroids have been the gastrointestinal equivalent of duct tape: they fix almost everything, at least long enough to convince us the job is done.…
Journal of Drugs in Dermatology JDD featuring GLP-1 Receptor Agonist Use for Diabetes Mellitus is Associated With Reduced Psoriasis Disease Severity

GLP-1 Receptor Agonist Use for Diabetes Mellitus is Associated With Reduced Psoriasis Disease Severity

| Featured Articles, GLP-1, Latest News | No Comments
GLP-1 Receptor Agonists and Psoriasis: The Next Frontier in Metabolic Dermatology? A groundbreaking study published in the Journal of Drugs in Dermatology  highlights a compelling link between metabolic therapy and…

Leave a Reply